Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
85 hedge funds and large institutions have $209M invested in Augmedix, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 9 closing their positions.
244% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 9
56% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 18
40% more capital invested
Capital invested by funds: $150M → $209M (+$59.7M)
33% more funds holding
Funds holding: 64 → 85 (+21)
20% more call options, than puts
Call options by funds: $3.5M | Put options by funds: $2.92M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$6.85M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$3.95M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$3.49M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$3.37M |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$2.76M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.03M |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
-$1.69M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.28M |
| 4 |
TC
TownSquare Capital
Provo,
Utah
|
-$735K |
| 5 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$714K |
AUGX Hedge Fund Activity: Q4 2023 in Review
85 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q4 2023, worth a combined $209M — up 40% from $150M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new AUGX positions and 9 closed out — a net gain of 22 holders — while 28 added to existing stakes and 18 trimmed.
The largest buyer was Divisadero Street Capital Management, adding an estimated $6.85M. The largest seller was Point72 Asset Management, cutting an estimated $2.03M.
- 85 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q4 2023, up from 64 in Q3 2023.
- Funds reported $209M of Augmedix, Inc. Common Stock stock for Q4 2023, up 40% quarter-over-quarter.
- 31 funds opened new Augmedix, Inc. Common Stock positions in Q4 2023 and 9 closed out, a net change of +22 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q4 2023 was Divisadero Street Capital Management, an estimated $6.85M added.
- The largest Augmedix, Inc. Common Stock seller in Q4 2023 was Point72 Asset Management, an estimated $2.03M sold.
Based on aggregated 13F filings for Q4 2023.